Cheung A, Lau H K
Biochim Biophys Acta. 1986 Jun 19;882(2):200-9. doi: 10.1016/0304-4165(86)90156-x.
A proteinase inhibitor has been isolated from human colorectal adenocarcinomas by extraction with a low-ionic-strength buffer and a combination of Con A-Sepharose, Sephadex G-200, DEAE-cellulose and chromatofocusing steps. The preparation appeared to be homogeneous upon gel exclusion chromatography and SDS-polyacrylamide gel electrophoresis and had an estimated molecular weight of 66,000. The inhibitor was able to bind and inhibit urokinase, plasmin, trypsin, tissue plasminogen activator and thrombin. The binding appeared to be stoichiometric and relatively fast. The isoelectric point of the protein was 4.6-4.7. The inhibitor did not crossreact with antisera elicited against alpha 2-macroglobulin, alpha 2-antiplasmin, antithrombin III or C1-inhibitor, but it did crossreact with an antiserum against alpha 1-antitrypsin in double immunodiffusion. The antiserum only partially attenuated the activity of the inhibitor. Whereas alpha 1-antitrypsin completely inhibited the amidolytic activity of elastase, the tumor inhibitor had no effect on elastase under the same conditions.
通过用低离子强度缓冲液提取,以及结合刀豆球蛋白A-琼脂糖、葡聚糖凝胶G-200、二乙氨基乙基纤维素和色谱聚焦步骤,从人结肠腺癌中分离出一种蛋白酶抑制剂。该制剂在凝胶排阻色谱和十二烷基硫酸钠-聚丙烯酰胺凝胶电泳中显示为均一的,估计分子量为66,000。该抑制剂能够结合并抑制尿激酶、纤溶酶、胰蛋白酶、组织纤溶酶原激活剂和凝血酶。这种结合似乎是化学计量的且相对较快。该蛋白质的等电点为4.6 - 4.7。该抑制剂与针对α2-巨球蛋白、α2-抗纤溶酶、抗凝血酶III或C1-抑制剂产生的抗血清不发生交叉反应,但在双向免疫扩散中与针对α1-抗胰蛋白酶的抗血清发生交叉反应。该抗血清仅部分减弱了抑制剂的活性。虽然α1-抗胰蛋白酶完全抑制弹性蛋白酶的酰胺水解活性,但在相同条件下肿瘤抑制剂对弹性蛋白酶没有影响。